Gallic acid ameliorates COPD-associated exacerbation in mice
- 23 September 2020
- journal article
- research article
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 476 (1) , 293-302
Abstract
COPD is an inflammatory lung disease, which is often exacerbated with microbial infections resulting in worsening of respiratory symptoms. Gallic acid (GA), a naturally occurring phenolic compound is known to possess anti-oxidant/anti-inflammatory activity. We have recently reported that GA protects against the elastase (ET) induced lung inflammation and emphysema and the present work was designed to investigate the beneficial effects of Gallic acid against ET + Lipopolysachharide (LPS) induced COPD exacerbation like condition in mice model. Our data showed that i.t. administration of LPS at 21 days after ET instillation resulted in significant infiltration of inflammatory cells particularly neutrophils (p < 0.0001) into the lungs along with elevated levels of pro-inflammatory cytokines like TNF-α, IL-1β and IL-6 (p < 0.0001). Interestingly, daily administration of GA (200 mg/Kg b. wt.) starting 7 days before ET instillation, significantly blunted the ET + LPS induced inflammation as indicated by reduced number of inflammatory cells particularly neutrophils (p < 0.0001) in BALF along with suppression of myeloperoxidase activity (p = 0.0009) and production of pro-inflammatory cytokines (p < 0.0001). Further, GA also restored the redox imbalance in the lungs towards normal. Additionally, phosphorylation of p65-NF-κB was found to be reduced (p = 0.015), which was associated with downregulation in the gene expression of IL-1β (p = 0.022) and TNF-α (p = 0.04). Conversely, GA treatment resulted in increased protein levels of Nrf2 (p = 0.021) with concomitant increase in transcription of its downstream target genes HO-1 (p = 0.033) and Prdx-1 (p = 0.006). Overall, our data show that GA effectively modulates COPD exacerbation manifestations in mice potentially by restoring redox imbalance in lungs.Keywords
Funding Information
- Department of Biotechnology , Ministry of Science and Technology (BT/PR17968/MED/122/33/2016)
- University Grants Commission (SAP)
- Indian Council of Medical Research (SRF)
This publication has 45 references indexed in Scilit:
- A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2008
- 2′,4′,6′-Tris(methoxymethoxy) chalcone protects against trinitrobenzene sulfonic acid-induced colitis and blocks tumor necrosis factor-α-induced intestinal epithelial inflammation via heme oxygenase 1-dependent and independent pathwaysBiochemical Pharmacology, 2007
- Pathophysiology of Exacerbations of Chronic Obstructive Pulmonary DiseaseProceedings of the American Thoracic Society, 2006
- Oxidative stress and airway inflammation in severe exacerbations of COPDThorax, 2005
- Nuclear localisation of p65 in sputum macrophages but not in sputum neutrophils during COPD exacerbationsThorax, 2003
- New Strains of Bacteria and Exacerbations of Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2002
- Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader11Mention of a trade name, proprietary product, or specific equipment does not constitute a guarantee by the United States Department of Agriculture and does not imply its approval to the exclusion of other products that may be suitable.Free Radical Biology and Medicine, 1999
- Assay for lipid peroxides in animal tissues by thiobarbituric acid reactionAnalytical Biochemistry, 1979
- Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liverBiochimica et Biophysica Acta (BBA) - General Subjects, 1979
- Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutaseArchives of Biochemistry and Biophysics, 1978